Aerosolized Pentamidine for Prophylaxis against Pneumocystis carinii Pneumonia The San Francisco Community Prophylaxis Trial
Pneumocystis carinii pneumonia (PCP) is the most frequent life-threatening opportunistic infection leading to the diagnosis of the acquired immunodeficiency syndrome (AIDS), having affected at least 70,000 persons in the United States since 1981. 1 In patients with human immunodeficiency virus (HIV)...
Saved in:
Published in | The New England journal of medicine Vol. 323; no. 12; pp. 769 - 775 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston, MA
Massachusetts Medical Society
20.09.1990
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pneumocystis carinii
pneumonia (PCP) is the most frequent life-threatening opportunistic infection leading to the diagnosis of the acquired immunodeficiency syndrome (AIDS), having affected at least 70,000 persons in the United States since 1981.
1
In patients with human immunodeficiency virus (HIV) infection, PCP is the most frequent cause of death.
2
In other immunosuppressed patients and patients with AIDS who have Kaposi's sarcoma, prophylaxis with trimethoprim–sulfamethoxazole has been successful in preventing PCP.
3
4
5
In HIV-infected patients, adverse effects of trimethoprim–sulfamethoxazole, parenteral pentamidine, and pyrimethamine—sulfadoxine have limited the long-term administration of these drugs.
6
In contrast, aerosolized pentamidine can be delivered directly to the alveolar . . . |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM199009203231201 |